← Leaderboards
Lawrence J Frye
Life Analytics, Inc.
$3,094,239
Attributed
$3,094,239
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2022–24$2M$1.5M$1M$500K$0
'22
'23
'24
Funding mix
By agency
NIH$3,094,239 · 1
By mechanism
R44$3,094,239 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAgingClinical TrialsDementiaBiological MarkersAmericanAging And TechnologyData CollectionAging PopulationAfrican AmericanConduct Clinical TrialsCaringCheckup ExaminationClinical ResearchData ExchangeAssociated SymptomBackCohortCommercializationCommunitiesComputer SoftwareBehaviorDigitalDisease Progression
Grant awards (4)
Optimization of an at-home continuous multi-domain monitoring and assessment system to improve Alzheimer's and related disorders clinical trials$1,216,858
R44 · FY2024 · AG · contact PI
Optimization of an at-home continuous multi-domain monitoring and assessment system to improve Alzheimer's and related disorders clinical trials$190,443
R44 · FY2024 · AG · contact PI
Optimization of an at-home continuous multi-domain monitoring and assessment system to improve Alzheimer's and related disorders clinical trials$1,233,110
R44 · FY2023 · AG · contact PI
Optimization of an at-home continuous multi-domain monitoring and assessment system to improve Alzheimer's and related disorders clinical trials$453,828
R44 · FY2022 · AG · contact PI